Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

596 Articles

Douglas A. McIntyre | Jun 4, 2008 at 6:53 AM EDT

Top 10 Pre-Market Analyst Calls (BMY, MAR, MS, NRG, OMRI, SNCR, TRMB, TSN, MTN, XNPT)

These are ten of the analyst calls we are focusing on this Wednesday morning in pre-market trading: Bristol-Myers (NYSE: BMY)…

Douglas A. McIntyre | Apr 28, 2008 at 11:20 AM EDT

Bristol-Myers Squibb Files Open Shelf Registration (BMY)

Bristol-Myers Squibb (NYSE: BMY) has submitted an open shelf offering today for an undetermined amount. The offering includes a combination…

Douglas A. McIntyre | Apr 24, 2008 at 7:03 AM EDT

Bristol-Myers Plans Partial Spin-Off of Nutritional Unit in IPO (BMY)

Bristol-Myers Squibb Company (NYSE: BMY) came out with earnings at $0.35 EPS and reaffirmed 2008 guidance of $1.36 to $1.46…

Douglas A. McIntyre | Apr 3, 2008 at 8:27 AM EDT

Medarex Says Forget Pfizer, Its Own Melanoma Study Continues (MEDX, PFE, BMY)

Medarex, Inc. (NASDAQ: MEDX) wants to clarify a few issues regarding the study halt from Pfizer (NYSE: PFE) this week…

Douglas A. McIntyre | Mar 17, 2008 at 5:17 AM EDT

Bristol-Myers (BMY) Looks To Sell Baby Food Business For As Much As $9 Billion

Bristol-Myers (NYSE: BMY) does not see much future in baby food. It is trying to sell its operation to a…

Douglas A. McIntyre | Mar 16, 2008 at 11:49 AM EDT

Bleak House: Despair On The 52-Week Low List (GE)(VZ)(GOOG)(C)

Those rummaging through the garbage of 52-week low lists are usually bottom-fishing investors or desperate CEOs. But, the list is…

Douglas A. McIntyre | Mar 14, 2008 at 4:44 AM EDT

Auction-Rate Securities Hit Mid-Cap Companies

Some large companies, like Bristol-Myers (BMY), has already said that auction-rate securities on their balance sheets may have to be…

Douglas A. McIntyre | Mar 12, 2008 at 12:59 PM EDT

IPO FILING: CyDex Pharmaceuticals, Inc. (CYDX, PFE, BMY, AZN)

CyDex Pharmaceuticals, Inc. has filed to come public via an IPO in what it lists for filing purposes as up…

Douglas A. McIntyre | Jan 7, 2008 at 11:46 PM EST

Cramer Chooses Among Dogs of Dow For Appreciation & Preservation (DOW, VZ, T, MO, BMY)

On tonight’s MAD MONEY on CNBC, Jim Cramer wanted to look for stocks with both appreciation potential that also offer…

Douglas A. McIntyre | Dec 17, 2007 at 10:49 AM EST

10 Turnarounds That Haven’t Turned Around: Pfizer (PFE, MRK, BMY, JNJ)

Early this week we are running a list of stocks that have been in a turnaround plan, yet the stocks…

Douglas A. McIntyre | Dec 10, 2007 at 4:57 PM EST

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Medarex inc. (NASDAQ: MEDX) is seeing shares slapped in after-hours trading after the company is issuing disappointing news over the…

Douglas A. McIntyre | Dec 6, 2007 at 4:10 AM EST

Media Digest 12/6/2007 Reuters, WSJ, NYTimes, FT, Barrons’

According to Reuters, Nikon is seeing a sharp increase in demand from LCD makers. Reuters writes that the housing slump…

Douglas A. McIntyre | Dec 5, 2007 at 12:33 PM EST

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

Bristol-Myers (BMY) showed the world its equivalent of the old Soviet "Five Year Plan" today. All of the talk up…

Douglas A. McIntyre | Nov 4, 2007 at 5:28 PM EST

A Little Trouble For Bristol-Myers (BMY) Plavix

Plavix from Bristol-Myers (BMY) is the medical drug-thinner of choice. According to CNN Money, sales of the drug "totaled $3.4…

Douglas A. McIntyre | Oct 17, 2007 at 7:51 AM EDT

Medarex Hit With Sell Rating (MEDX, BMY)

Medarex (NASDAQ:MEDX) is seeing shares being hit by a research note where Banc of America initiated coverage with a "SELL"…

1 … 37 38 39 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Top 10 Pre-Market Analyst Calls (BMY, MAR, MS, NRG, OMRI, SNCR, TRMB, TSN, MTN, XNPT)

Bristol-Myers Squibb Files Open Shelf Registration (BMY)

Bristol-Myers Plans Partial Spin-Off of Nutritional Unit in IPO (BMY)

Medarex Says Forget Pfizer, Its Own Melanoma Study Continues (MEDX, PFE, BMY)

Bristol-Myers (BMY) Looks To Sell Baby Food Business For As Much As $9 Billion

Bleak House: Despair On The 52-Week Low List (GE)(VZ)(GOOG)(C)

Auction-Rate Securities Hit Mid-Cap Companies

IPO FILING: CyDex Pharmaceuticals, Inc. (CYDX, PFE, BMY, AZN)

Cramer Chooses Among Dogs of Dow For Appreciation & Preservation (DOW, VZ, T, MO, BMY)

10 Turnarounds That Haven’t Turned Around: Pfizer (PFE, MRK, BMY, JNJ)

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Media Digest 12/6/2007 Reuters, WSJ, NYTimes, FT, Barrons’

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

A Little Trouble For Bristol-Myers (BMY) Plavix

Medarex Hit With Sell Rating (MEDX, BMY)

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Top 10 Pre-Market Analyst Calls (BMY, MAR, MS, NRG, OMRI, SNCR, TRMB, TSN, MTN, XNPT)

Bristol-Myers Squibb Files Open Shelf Registration (BMY)

Bristol-Myers Plans Partial Spin-Off of Nutritional Unit in IPO (BMY)

Medarex Says Forget Pfizer, Its Own Melanoma Study Continues (MEDX, PFE, BMY)

Bristol-Myers (BMY) Looks To Sell Baby Food Business For As Much As $9 Billion

Bleak House: Despair On The 52-Week Low List (GE)(VZ)(GOOG)(C)

Auction-Rate Securities Hit Mid-Cap Companies

IPO FILING: CyDex Pharmaceuticals, Inc. (CYDX, PFE, BMY, AZN)

Cramer Chooses Among Dogs of Dow For Appreciation & Preservation (DOW, VZ, T, MO, BMY)

10 Turnarounds That Haven’t Turned Around: Pfizer (PFE, MRK, BMY, JNJ)

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Media Digest 12/6/2007 Reuters, WSJ, NYTimes, FT, Barrons’

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

A Little Trouble For Bristol-Myers (BMY) Plavix

Medarex Hit With Sell Rating (MEDX, BMY)

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income